Medical advances are such that biomedical materials and artificial tissues are constantly being developed to repair, replace and enhance natural tissues. Biomaterials must maintain their strength and stability following implantation and Collagen, the most widely used matrix for tissue engineering, undergoes a constant process of remodelling and reshaping in vivo.
Now researchers at the University of Strathclyde have discovered a safe method to slow down the rate at which collagen scaffolds are degraded. Fibroblast-seeded collagen hydrogels treated with existing FDA-approved drugs demonstrated increased stiffness compared to untreated hydrogels, with no significant changes to tissue permeability.